Iovance Biotherapeutics
Tim Logan is the VP of Global Commercial Operations at Iovance Biotherapeutics, Inc. Previously, Tim held various senior director roles at Gilead Sciences, overseeing corporate development, competitive intelligence, portfolio analytics, global analytics, and market research. Prior to that, Tim worked as a consultant at ZS Associates in life science management and strategy. Tim also has experience in research and entrepreneurship, having worked as a doctoral researcher at UC Berkeley and as the founder and CTO of a nanotechnology start-up. Tim holds a Ph.D. in Chemical Engineering from UC Berkeley, along with a degree in Management of Technology and Chemical Engineering from Brown University.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.